FABIAN Posters bio
analyse
.org
Home
Agenda
Archief
Netwerk
Nieuws | News
Symposia
Werkgroep

FABIAN 2009 - Sustainable Bioanalysis - Solvay Pharmaceuticals, 10 November 2009

Program
Abstracts
Posters
Submission
Slides
Hotels
Directions

 

FABIAN 2009

 Socially Responsible Bioanalysis

10 November 2009, Solvay Pharmaceuticals, Weesp

To submit a poster follow the instructions on submissie.htm

Poster Title
Abstract

Radioactive measurement: Combustion or Dissolving - Radioactive measurement of feces, blood, liver, brain or fat tissue, a Comparison of Dissolving with Combustion
E. Beek-van Velzen (Solvay Pharmaceutical Research Laboratories, C.J. van Houtenlaan 36, 1381 CP Weesp, The Netherlands)

09P01

Bioanalytical Method Development for Therapeutic Peptides
Erin Chambers (Waters Corporation)

09P02

A Leap Forward in Sensitivity and Selectivity for PAH Analysis using GC-APLI-TOF/MS
Rob van der Heijden1, Patrick van Houts1, George McLeod2, Thomas Arthen-Engeland3, Carsten Baessmann3, Armin Holle3 (1. Bruker Daltonics BV, PO Box 88, 1530 AB, Wormer, The Netherlands, 2. Bruker Daltonics, Coventry, United Kingdom and 3. Bruker Daltonik GmbH, Bremen, Germany)

09P03

Improved Peptide Identification with an Ultra High Resolution Quadrupole Time of Flight MS (maXis)
Patrick van Houts1, Rob van der Heijden1, Markus Lubeck2, Marina Behrens2, Andrea Schneider2, Carsten Baessmann2 and Oliver Raether2 (1. Bruker Daltonics, Wormer, The Netherlands and 2. Bruker Daltonik, Bremen, Germany)

09P04

Detection of Metabolites in Urine at Microdosing Levels in Rats Using LC-MS/MS
Carmai Seto1, Tanya Gamble1, Takeo Sakuma1, Jinsong Ni2, Fred Ouyang2, Devin Welty2 and Andrew Acheampong2 (1. Applied Biosystems/MDS Analytical Technologies, 71 Four Valley Drive, Concord, Ontario, Canada and 2. Dept of Drug Safety Evaluation, Allergan, Irvine, CA, USA)

09P05
Increased Selectivity Without Loss of Sensitivity: Use of LC-MS3 for Sensitive Additional Structure Information and LC-MRM3 for Highly Selective Quantification
Axel Besa and Jan Lembcke (Applied Biosystems Germany, Frankfurter Straße 129 B, 64293 Darmstadt, Germany)
09P06

High Throughput Screening of GSH Adducts Using Hybrid Linear Ion Trap Systems Coupled with Fast Chromatography at Clinically Relevant Dose Concentrations
Hua-fen Liu1, Hesham Ghobarah2 , Renee Huang1, Jens Dahlmann3 and Elliott Jones1 (Applied Biosystems, part of Life Technologies, (1) Foster City, USA, (2) Concord, Canada, (3) Darmstadt, Germany)

09P07

Simultaneous quantification of testosterone and androstenedione in human serum using LC-MS/MS
E. Joos1,2, J. Van Bocxlaer2, M. Vandermarliere1 and K. Croes1 (1. Clinical Laboratory, AZ Groeninge, Reepkaai, B-8500 Kortrijk. Belgium & 2. Laboratory for Medical Biochemistry and Clinical Analysis, Fac. Pharm. Sci., Ghent University, Harelbekestraat 72, B-9000 Gent. Belgium)

09P08

CHIRAL LC-MS-MS DETERMINATION OF (R)- AND (S)-CITALOPRAM IN HUMAN PLASMA SAMPLES
E. Mallat, V. Jas, J. Flik, M. Boterman, K. de Jonge (Analytisch Biochemisch Laboratorium (ABL) BV, Scholtenstraat 7, Assen, The Netherlands)

09P09

A sensitive LC-MS/MS method for the separate quantification of gentamicin C1, C1a, C2 and C2a in bovine tissue.
M. Boterman, M.J. Dröge, F. Oostebring, F. Venema & E. Oosting (Analytisch Biochemisch Laboratorium (ABL) BV, Assen, The Netherlands)

09P10

A sensitive automated online SPE-LC-MS/MS method for the quantitative determination of ivermectin B1a in bovine plasma.
M. Boterman1, M.J. Dröge1, F. Oostebring1, M.A.H. Boezeman2 and E. Oosting1 (1. Analytisch Biochemisch Laboratorium (ABL) BV, Assen, The Netherlands and 2. Farma Research Animal Health (FRAH) BV, Nijmegen, The Netherlands)

09P11

New UHPLC systems from Eksigent Technologies for improved performance in LC/MS
Rein Reitsma (Separations Analytical Instruments)

09P12

DRIED BLOOD SPOTS FOR TK/PK AND BIOMARKER ANALYSIS AND 3R
Elwin Verheij (TNO Quality of Life, PO Box 360, 3700 AJ Zeist)

09P13

Generic solid phase extraction procedure for the quantitative analysis of peptides in plasma
H. Korthals, H. Gerritsen, R. Brust-van Schaik and B. Buscher* (TNO Quality of Life, Zeist, The Netherlands)

09P14

EX VIVO HUMAN SKIN MODEL FOR PHOTOGENOTOXICITY TESTING
AA Reus, FAA van Acker, CAM Krul (TNO Quality of Life, Zeist, The Netherlands)

09P15

Monitoring Matrix EffectsM in Biological Samples Utilizing Dual Scan MRM Mode Mass Spectrometry
Paul D Rainville, Joanne Mather, Robert S Plumb, Jing Lin (Waters Corporation, Milford, MA)

09P16

The CMA 64 IView microdialysis Catheter
Noud Grimberg (Aurora Borealis Control B.V., Postbus 2, 7760 AA Schoonebeek)

09P17

Accuracy of incurred sample results, the final validation challenge in quantitative bioanalysis ?
Theo de Boer, Marjan Hagenouw, Rudy Francke and Jaap Wieling (Xendo Drug Development B.V., Hanzeplein 1, NL-9713 GZ Groningen, The Netherlands)

09P18

Application of Dried Blood Spot sampling within clinical trials: Feasibility study of pardoprunox, a potent anti-Parkinson Drug
O.A.M. Brockhoff1, P.H. van Amsterdam1, J. Thomson2, C. Troupe3 (1. Solvay Pharmaceuticals, Global Bioanalytics Department, Weesp, The Netherlands 2. Aptuit Inc, Riccarton, Scotland, 3. Quintiles Laboratories, Marietta, GA, USA)

09P19
* Contact

Program ] Abstracts ] [ Posters ] Submission ] Slides ] Hotels ] Directions ]
2001 ] 2002 ] 2003 ] 2004 ] 2005 ] 2006 ] 2007 ] 2008 ] 2009 ]

Last update
06-Nov-09